Abstract
When determining the place of Quality Assurance groups within companies, management uses arguments to defend their preferred structures. These are typically the ‘vertical’ structure and the ‘site-based’ structure. In this article the author defends the situation that since Quality Assurance Professionals perform essentially similar work throughout the GXP scenario in Pharmaceutical R&D, a matrix approach is the most suitable to meet their principle functions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
